Research & development

Lizard venom could treat blood clots

11 August, 2017

An international research team is studying various types of lizard venom as possible treatments for blood-clotting diseases.

Gut bacteria composition affects nutritional choices

01 August, 2017

Two new studies have revealed that the gut bacteria composition affects nutritional choices as well as reproduction, using common fruit flies as a model system.

Walter and Eliza Hall in $400m royalties deal for cancer drug

28 July, 2017

The Walter and Eliza Hall Institute of Medical Research has made a landmark deal worth up to US$325 million ($408 million) from the partial sale of royalty rights for anticancer treatment venetoclax.

Complex immune system changes observed after traumatic injury

24 July, 2017

Within the first hour after experiencing a traumatic injury, a person's immune system undergoes a series of complex, dynamic changes, reveals a new study.

Cucumbers in space

24 July, 2017

Japanese scientists have grown cucumbers in space flight.

Tiny implantable 'seeds' of tissue produce fully functional livers

24 July, 2017 by Anne Trafton, MIT News Office 

In an effort to ease the shortage of livers, US researchers have developed a new way to engineer liver tissue by organising tiny subunits that contain three types of cells embedded into a biodegradable tissue scaffold.

Ebola-fighting super cell discovered

18 July, 2017

Australian and American researchers have discovered a super cell that may have the potential to help contain the Ebola virus.

Gut flora an early marker for heart failure?

14 July, 2017

In the gut of patients with heart failure, important groups of bacteria are found less frequently and the gut flora is not as diverse as in healthy individuals.

Mother's epigenetic memory essential for embryo development and survival

14 July, 2017

It has long been debated if epigenetic modifications accumulated throughout the entire life can cross the border of generations and be inherited by children or even grandchildren.

Gonorrhoea resistance on the rise; new drugs needed

07 July, 2017

Each year around 78 million people are infected with gonorrhoea, a common sexually transmitted infection.

Personalised vaccine prompts strong anti-tumour response in patients

06 July, 2017

A personal cancer treatment vaccine that targets distinctive 'neoantigens' on tumour cells has been shown to stimulate a potent, safe and highly specific immune anti-tumour response in melanoma patients, reported scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

Australian-Canadian partnership for medical cannabis

04 July, 2017

LeafCann Group, a Melbourne-based medical cannabis producer, has formed a joint venture with Canadian developer of medical cannabis delivery systems and devices Resolve Digital Health.

Skin cancer costs 30 times more to treat than prevent

03 July, 2017

Despite being largely preventable, skin cancer costs Victoria's public hospitals more than $50 million a year, new research from Deakin University and Cancer Council Victoria has found.

Aus cancer vaccine closer to human trials

30 June, 2017

Radvax, a cancer treatment vaccine, being developed by South Australian company Vaxine, is closer to human trials.

Cancer cells may streamline their genomes to replicate faster

26 June, 2017

A recent study, conducted in both human and mouse cells, has revealed that cancer cells might streamline their genomes in order to proliferate more easily.

  • All content Copyright © 2019 Westwick-Farrow Pty Ltd